Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)
China
· Delayed Price · Currency is CNY 4.000
-0.030 (-0.74%)
Mar 11, 2026, 3:00 PM CST
SHA:600594 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -234.63 | -317.22 | 103.4 | -426.39 | 243.77 | 228.76 | Upgrade
|
| Depreciation & Amortization | 192.69 | 192.69 | 201.11 | 181.48 | 149.94 | 140.9 | Upgrade
|
| Other Amortization | 34.34 | 34.34 | 28.16 | 46.9 | 53.24 | 35.31 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.78 | -0.78 | -0.02 | -31.05 | 1.37 | -12.7 | Upgrade
|
| Asset Writedown & Restructuring Costs | 58.02 | 58.02 | 19.93 | 627.43 | 142.19 | 163.5 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.34 | -0.34 | -0.03 | -1.83 | -34.64 | 4.23 | Upgrade
|
| Provision & Write-off of Bad Debts | -5.04 | -5.04 | -3.19 | -0.27 | 7.43 | -1.08 | Upgrade
|
| Other Operating Activities | -36.58 | 42.02 | 104.2 | 49.38 | 72.84 | 51.47 | Upgrade
|
| Change in Accounts Receivable | 184.28 | 184.28 | 44.61 | 69.38 | 241.25 | -185.85 | Upgrade
|
| Change in Inventory | 41.75 | 41.75 | -26.6 | -88.41 | -87.09 | -71.9 | Upgrade
|
| Change in Accounts Payable | -105.38 | -105.38 | -88.77 | -57.63 | 137.14 | 9.82 | Upgrade
|
| Operating Cash Flow | 90.87 | 86.87 | 377.61 | 345.3 | 934.21 | 366.66 | Upgrade
|
| Operating Cash Flow Growth | -61.21% | -76.99% | 9.36% | -63.04% | 154.79% | 1.09% | Upgrade
|
| Capital Expenditures | -48.49 | -96.32 | -130.38 | -322.92 | -447.78 | -395.74 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.2 | 1.17 | 0.09 | 4.78 | 6.63 | 2.73 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -332.04 | - | Upgrade
|
| Divestitures | - | - | - | - | -18.56 | -0.06 | Upgrade
|
| Investment in Securities | -20 | -19.99 | - | -20 | 100.71 | -98.95 | Upgrade
|
| Other Investing Activities | -2.13 | 11.3 | 14.7 | 30.37 | 3.37 | 64.24 | Upgrade
|
| Investing Cash Flow | -70.42 | -103.84 | -115.59 | -307.78 | -687.67 | -427.78 | Upgrade
|
| Long-Term Debt Issued | - | 560 | 741.33 | 895.7 | 1,095 | 917.48 | Upgrade
|
| Long-Term Debt Repaid | - | -607.83 | -850.84 | -743.72 | -1,393 | -1,071 | Upgrade
|
| Net Debt Issued (Repaid) | -7.21 | -47.83 | -109.51 | 151.98 | -297.81 | -153.81 | Upgrade
|
| Repurchase of Common Stock | -25 | -25 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -29.88 | -86.87 | -41.18 | -49.11 | -152.12 | -549.2 | Upgrade
|
| Other Financing Activities | 25.46 | - | -1 | 66 | -35.08 | - | Upgrade
|
| Financing Cash Flow | -36.63 | -159.71 | -151.69 | 168.87 | -485.01 | -703.02 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | -0 | - | - | - | - | Upgrade
|
| Net Cash Flow | -16.18 | -176.67 | 110.33 | 206.39 | -238.47 | -764.13 | Upgrade
|
| Free Cash Flow | 42.37 | -9.45 | 247.23 | 22.38 | 486.43 | -29.08 | Upgrade
|
| Free Cash Flow Growth | -69.32% | - | 1004.93% | -95.40% | - | - | Upgrade
|
| Free Cash Flow Margin | 2.22% | -0.43% | 8.77% | 0.82% | 14.54% | -0.85% | Upgrade
|
| Free Cash Flow Per Share | 0.05 | -0.01 | 0.31 | 0.03 | 0.61 | -0.04 | Upgrade
|
| Cash Income Tax Paid | 177.96 | 193.74 | 318.26 | 304.93 | 379.86 | 454.74 | Upgrade
|
| Levered Free Cash Flow | 67.26 | 89.93 | 150.26 | -107.51 | 288.92 | 66.84 | Upgrade
|
| Unlevered Free Cash Flow | 81.35 | 106.42 | 163.78 | -84.09 | 310.88 | 92.63 | Upgrade
|
| Change in Working Capital | 83.19 | 83.19 | -75.95 | -100.34 | 298.07 | -243.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.